Samantha McLemore’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Samantha McLemore’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,631	Closed	-$3.68M	–	45
2023 Q4	$3.68M	Sell	11,631 -164,621	-93%	-$32M	0.2%	36
2023 Q3	$29.8M	Sell	176,252 -574	-0.3%	-$108K	1.75%	27
2023 Q2	$38.3M	Buy	176,826 +153,451	+656%	+$32.9M	2.13%	26
2023 Q1	$4.25M	Buy	23,375 +5,675	+32%	+$1.09M	1.89%	29
2022 Q4	$3.48M	Hold	17,700	–	–	1.69%	28
2022 Q3	$3.98M	Sell	17,700 -1,600	-8%	-$324K	1.99%	25
2022 Q2	$2.44M	Buy	19,300 +1,500	+8%	+$172K	1.08%	33
2022 Q1	$2.26M	Sell	17,800 -1,400	-7%	-$158K	0.76%	39
2021 Q4	$2.52M	Buy	+19,200	New	+$2.48M	0.72%	40

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Samantha McLemore's KRTX Position: Q1 2024 in Review

Samantha McLemore sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 11,631 shares — an estimated $3.68M sold.

Samantha McLemore first reported a position in KRTX in Q4 2021 and held it in 9 quarters. The position peaked at $38.3M in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Samantha McLemore reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Samantha McLemore sold 11,631 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.68M.
Samantha McLemore first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
Samantha McLemore's Karuna Therapeutics, Inc. Common Stock position peaked at $38.3M in Q2 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Patient Capital Management's 13F filing for Q1 2024, filed 15 May 2024.